U.S.-Israel War on Iran Escalates as Gulf Conflict Disrupts Oil, Air Travel and Regional Security 
Dollar Rallies as Middle East Conflict Weighs on Yen and Euro, Lifts Safe-Haven Demand 
Blackstone’s BCRED Fund Sees $1.7B Net Outflows as Private Credit Concerns Shake Investors 
Global Markets React as Dollar Surges, Swiss Franc Rallies After U.S.-Israel Strike on Iran 
Fitch Downgrades Paramount Skydance and Paramount Global to Junk Amid Warner Bros Discovery Deal Concerns 
DBS Wins Key Licence to Underwrite Corporate Bonds in China’s Interbank Market 
Facebook Outage Disrupts Thousands of Users Across the United States 
APEX Tech Acquisition Inc. Raises $111.97 Million in NYSE IPO Under Ticker TRADU 
Australia Targets AI Platforms With Strict Age Verification Rules 
Shell to Invest $667M in Brazil’s Struggling Sugar and Ethanol Producer Raizen 
AWS Data Center in UAE Hit by Fire After Objects Strike Facility Amid Regional Tensions 
Rio Tinto Advances Gallium Extraction Project in Canada with Federal Funding Support 
Lockheed Martin Secures $1.9B U.S. Air Force Contract for C-130J Training and Maintenance Systems 
Rachel Reeves Signals Fiscal Discipline in UK Budget Update Amid Middle East Tensions 
U.S. Officials Review Tencent’s Stakes in Epic Games, Riot Games Over Security Concerns 
PBOC Scraps Forex Risk Reserve as Yuan Rally Pressures Chinese Exporters 
Argentina Tax Reform 2026: President Javier Milei Pushes Lower Taxes and Structural Changes 
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
